Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers

  Ischemic Heart Disease

  Free Subscription


5 Am J Cardiol
2 Am J Med
1 Angiology
2 Ann Intern Med
2 Ann Thorac Surg
1 Circ Cardiovasc Imaging
3 Circ Cardiovasc Qual Outcomes
1 Circulation
1 Clin Cardiol
1 Clin Chem
3 J Am Coll Cardiol
1 J Clin Endocrinol Metab
1 Mayo Clin Proc
2 Prog Cardiovasc Dis
1 Thromb Haemost

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Cardiol

  1. MINANA G, Cordero A, Facila L, Company M, et al
    Lipoprotein(A) and Long-Term Recurrent Infarction after an Acute Myocardial Infarction.
    Am J Cardiol. 2023 Oct 17:S0002-9149(23)01158.
    PubMed         Abstract available

  2. CHANG HY, Huang CC, Hung CS, Meng SW, et al
    Accurate Prediction of Retrograde Collateral Channel Crossing in Coronary Artery Chronic Total Occlusion Intervention.
    Am J Cardiol. 2023 Oct 14:S0002-9149(23)01161.
    PubMed         Abstract available

  3. SAINBAYAR E, Ibrahim R, Pham HN, Beauti W, et al
    Social Vulnerability and Hemopericardial Cardiovascular Death: Insight from the CDC Databases.
    Am J Cardiol. 2023 Oct 14:S0002-9149(23)01163.

  4. ARORA S, Jaswaney R, Khawaja T, Jain A, et al
    Outcomes With Intravascular Ultrasound and Optical Coherence Tomography Guidance in Percutaneous Coronary Intervention.
    Am J Cardiol. 2023;207:470-478.
    PubMed         Abstract available

  5. SINGH S, Jain A, Goel S, Garg A, et al
    Role of Intravascular Imaging in Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials.
    Am J Cardiol. 2023;208:143-152.
    PubMed         Abstract available

    Am J Med

  6. MAS-LLADO C, Rossello X, Gonzalez-Del-Hoyo M, Pocock S, et al
    Secondary prevention therapies in real-world patients with myocardial infarction: eligibility based on randomized trials supporting European and American guidelines.
    Am J Med. 2023 Oct 12:S0002-9343(23)00613-7. doi: 10.1016/j.amjmed.2023.
    PubMed         Abstract available

  7. ASCARIZ LF, Mundina BR, Mato EG, Posse JL, et al
    Frank s Sign and cardiovascular risk: an observational descriptive study.
    Am J Med. 2023 Oct 11:S0002-9343(23)00615-0. doi: 10.1016/j.amjmed.2023.
    PubMed         Abstract available


  8. LIU JH, Liu M, Mo DG
    Serum Amyloid A: A Potential Predictive Indicator of Infarct-Related Artery Patency in Patients With ST-Segment Elevation Myocardial Infarction.
    Angiology. 2023 Oct 14:33197231206431. doi: 10.1177/00033197231206431.

    Ann Intern Med

  9. BUDOFF MJ, Nasir K, Blaha MJ
    Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort.
    Ann Intern Med. 2023;176:eL230262.

  10. KOFOED KF, Fuchs A, Kober LV
    Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort.
    Ann Intern Med. 2023;176:eL230263.

    Ann Thorac Surg

  11. AHMED A, Iribarne A
    Heterogeneity Among Institutional Red Blood Cell Transfusion Rates With Coronary Artery Bypass Grafting.
    Ann Thorac Surg. 2023 Oct 13:S0003-4975(23)01059.

  12. GAUDINO M, Di Franco A, Arbustini E, Bacha E, et al
    Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art Review.
    Ann Thorac Surg. 2023 Oct 16:S0003-4975(23)00977.
    PubMed         Abstract available


  13. LEE YJ, Hong SJ, Kang WC, Hong BK, et al
    Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial.
    BMJ. 2023;383:e075837.
    PubMed         Abstract available

    Circ Cardiovasc Imaging

  14. ARAI M, Fujino M, Fujita T, Noguchi T, et al
    Left Coronary Artery Aneurysm Causing a Third Mogul.
    Circ Cardiovasc Imaging. 2023;16:e015441.

    Circ Cardiovasc Qual Outcomes

  15. LAUFFENBURGER JC, Jackevicius CA
    Complex Picture of Prescription Drug Discount Programs and Out-of-Pocket Costs in Cardiovascular Disease.
    Circ Cardiovasc Qual Outcomes. 2023;16:e010329.

  16. THOMPSON MP, Hou H, Stewart JW 2nd, Pagani FD, et al
    Relationship Between Community-Level Distress and Cardiac Rehabilitation Participation, Facility Access, and Clinical Outcomes After Inpatient Coronary Revascularization.
    Circ Cardiovasc Qual Outcomes. 2023 Oct 19:e010148.
    PubMed         Abstract available

  17. ALHASSAN HA, Akunor H, Howard A, Donohue J, et al
    Comparison of Atherosclerotic Cardiovascular Risk Factors and Cardiometabolic Profiles Between Current and Never Users of Marijuana.
    Circ Cardiovasc Qual Outcomes. 2023 Oct 20:e009609.
    PubMed         Abstract available


  18. RAYCHEV R, Sun JL, Schwamm L, Smith EE, et al
    Performance of Thrombectomy-Capable, Comprehensive, and Primary Stroke Centers in Reperfusion Therapies for Acute Ischemic Stroke: Report From the Get With The Guidelines-Stroke Registry.
    Circulation. 2023 Oct 19. doi: 10.1161/CIRCULATIONAHA.123.066114.
    PubMed         Abstract available

    Clin Cardiol

  19. LOUTATI R, Perel N, Bruoha S, Taha L, et al
    Troponin level at presentation as a prognostic factor among patients presenting with non-ST-segment elevation myocardial infarction.
    Clin Cardiol. 2023 Oct 19. doi: 10.1002/clc.24166.
    PubMed         Abstract available

    Clin Chem

  20. MARSTON NA, Vassy JL
    A Tale of Two Scores: Comparing Coronary Artery Calcium and Polygenic Risk Scores for the Prediction of Coronary Heart Disease Events.
    Clin Chem. 2023 Oct 19:hvad150. doi: 10.1093.

    J Am Coll Cardiol

  21. MEHRAN R, Vogel B
    The Heart-Brain Connection in Myocardial Infarction in Women: A Dilemma to Tackle.
    J Am Coll Cardiol. 2023;82:1659-1661.

  22. HAUSVATER A, Spruill TM, Xia Y, Smilowitz NR, et al
    Psychosocial Factors of Women Presenting With Myocardial Infarction With or Without Obstructive Coronary Arteries.
    J Am Coll Cardiol. 2023;82:1649-1658.
    PubMed         Abstract available

  23. GAUDINO M, Di Franco A, Arbustini E, Bacha E, et al
    Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art Review.
    J Am Coll Cardiol. 2023 Oct 16:S0735-1097(23)06455.
    PubMed         Abstract available

    J Clin Endocrinol Metab

  24. BOUZEMANE A, Vignot E, Dubourg LD, De Mul A, et al
    Reassuring data on the cardiovascular risk in adults with X-linked hypophosphatemia receiving conventional therapy.
    J Clin Endocrinol Metab. 2023 Oct 16:dgad608. doi: 10.1210.
    PubMed         Abstract available


  25. TAJEU GS, Joynt Maddox K, Brewer LC
    Million Hearts Cardiovascular Disease Risk Reduction Model.
    JAMA. 2023;330:1430-1432.

  26. JURASCHEK SP, Hu JR, Cluett JL, Ishak AM, et al
    Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis.
    JAMA. 2023;330:1459-1471.
    PubMed         Abstract available

    Mayo Clin Proc

  27. HERRAIZ-ADILLO A, Higueras-Fresnillo S, Ahlqvist VH, Berglind D, et al
    Life's Essential 8 and Life's Simple 7 in Relation to Coronary Atherosclerosis: Results From the Population-Based SCAPIS Project.
    Mayo Clin Proc. 2023 Oct 13:S0025-6196(23)00190.
    PubMed         Abstract available

    Prog Cardiovasc Dis

  28. CILIBERTI G, Guerra F, Pizzi C, Merlo M, et al
    Characteristics of patients with recurrent acute myocardial infarction after MINOCA.
    Prog Cardiovasc Dis. 2023 Oct 16:S0033-0620(23)00109.
    PubMed         Abstract available

  29. ROZANSKI A, Han D, Miller RJH, Gransar H, et al
    Comparison of coronary artery calcium scores among patients referred for cardiac imaging tests.
    Prog Cardiovasc Dis. 2023 Oct 17:S0033-0620(23)00108.
    PubMed         Abstract available

    Thromb Haemost

  30. PEDERSEN OB, Hvas AM, Pasalic L, Kristensen SD, et al
    Platelet Function and Maturity and Related microRNA Expression in Whole Blood in Patients with ST-Segment Elevation Myocardial Infarction.
    Thromb Haemost. 2023 Oct 16. doi: 10.1055/s-0043-1776305.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.